Top 50 Biotechnology Angel Investors in United Kingdom (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
29 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Nadav Rosenberg
Angel
|
5 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Biotechnology, Artificial Intelligence, Software | $850k–$19M |
|
Milad Alucozai
Angel
|
3 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | $110k–$60M |
|
Peder Nielsen
Angel
|
3 | United Kingdom | Seed, Convertible Note | Biotechnology, Machine Learning | |
|
Charlie Songhurst
Angel
|
3 | United Kingdom, United States, Germany | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $500k–$8M |
|
Jude Gomila
Angel
|
3 | United States, United Kingdom, India | Seed, Pre-Seed, Angel | Software, Biotechnology, Information Technology | $70k–$5M |
|
Stefano Bernardi
Angel
|
3 | Italy, United Kingdom, France | Seed, Pre-Seed | Software, Biotechnology, Artificial Intelligence | $100k–$45M |
|
Paul Wicks
Angel
|
3 | United Kingdom, United States, Japan | Seed, Pre-Seed, Series A | Software, Wellness, E-Commerce | $539k–$11M |
|
Jeff Dean
Angel
|
3 | United States, United Kingdom, Japan | Seed, Series A, Pre-Seed | Artificial Intelligence, Information Technology, Software | $450k–$60M |
|
Ian Hogarth
Angel
|
3 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, E-Commerce | $668k–$28M |
|
DrPano Kroko Churchill
Angel
|
3 | United Kingdom | Angel, Series A | Health Care, Therapeutics, Biotechnology | $150k–$458k |
|
Darrin Disley
Angel
|
3 | United Kingdom | Seed, Series A | Biotechnology, Health Care, Big Data | $458k–$3.7M |
|
Pratima Aiyagari
Angel
|
2 | United Kingdom, France, Germany | Seed, Pre-Seed, Series A | SaaS, Software, Analytics | $982k–$12M |
|
Gilad Engel
Angel
|
2 | France, Israel, United Kingdom | Seed, Pre-Seed | Hardware, Analytics, Biotechnology | $1.2M–$1.9M |
|
Inaki Berenguer
Angel
|
2 | Spain, United States, United Kingdom | Seed, Angel, Pre-Seed | FinTech, E-Commerce, Financial Services | $233k–$9M |
|
Patrick Pichette
Angel
|
2 | United Kingdom, Germany, United States | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $943k–$95M |
|
Jon Oringer
Angel
|
2 | United States, France, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, Health Care | $175k–$56M |
|
Mati Staniszewski
Angel
|
2 | United States, United Kingdom, Poland | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, SaaS | $2M–$75M |
|
Chris Mairs
Angel
|
2 | United Kingdom, United States | Seed, Pre-Seed, Angel | Software, FinTech, Financial Services | $334k–$3.7M |
|
Aidan Gomez
Angel
|
2 | United States, United Kingdom, Canada | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | $1.8M–$12M |
|
Bradley Horowitz
Angel
|
2 | United States, United Kingdom, Germany | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $150k–$120M |
|
Nadav Ben-Chanoch
Angel
|
2 | United States, France, United Kingdom | Seed, Pre-Seed | Software, Information Technology, Health Care | $100k–$5.5M |
|
Mark Evans
Angel
|
2 | United Kingdom, United States, The Netherlands | Series A, Seed, Series C | Software, E-Commerce, Health Care | $1.4M–$24M |
|
Damien Lane
Angel
|
2 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Series A | SaaS, Software, Health Care | $459k–$16M |
|
Serge Chiaramonte
Angel
|
2 | United Kingdom, United States, France | Seed, Pre-Seed | FinTech, Financial Services, Information Technology | $637k–$37M |
|
Paul Forster
Angel
|
2 | United Kingdom, Germany, United States | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $1.1M–$18M |
|
Ed Parkinson
Angel
|
2 | United Kingdom | Seed | Software, Health Care, Life Science | $1.8M–$3M |
|
Michelle Tempest
Angel
|
2 | United Kingdom | Seed, Pre-Seed, Series A | Health Care, Biotechnology, Cannabis | |
|
Jim Mellon
Angel
|
2 | United States, United Kingdom, Germany | Series A, Seed | Biotechnology, Food and Beverage, Health Care | |
|
Tim Dempsey
Angel
|
2 | United Kingdom | Seed, Series A | Software, SaaS, Financial Services | $962k–$13M |
|
Ariel Poler
Angel
|
2 | United States, Spain, Mexico | Seed, Series A, Angel | Software, Social Media, Internet | $455k–$7.9M |
|
Robert Kopple
Angel
|
2 | United States, United Kingdom | Convertible Note | FinTech, Finance, Life Science | |
|
Hugh Grant
Angel
|
2 | United Kingdom | Seed | Biotechnology, Machine Learning | |
|
Edward Lando
Angel
|
2 | United States, France, United Kingdom | Seed, Pre-Seed | Software, Health Care, Information Technology | $125k–$6.1M |
|
Amar Shah
Angel
|
2 | United Kingdom, Poland, Germany | Pre-Seed, Seed, Angel | Artificial Intelligence, Software, Health Care | $642k–$15M |
|
Martin Chavez
Angel
|
1 | United States, United Kingdom | Series A, Seed, Private Equity | Health Care, Machine Learning, Biotechnology | |
|
Ahmed Medhat
Angel
|
1 | United States, United Kingdom | Seed, Pre-Seed | Information Technology, Apps, Manufacturing | |
|
Huw Bishop
Angel
|
1 | United Kingdom | Angel | EdTech, Training, E-Learning | |
|
Sam Harris
Angel
|
1 | United Kingdom | Pre-Seed | Wellness, Elder Care, Health Care | |
|
Dave DeWalt
Angel
|
1 | United States, Israel, United Kingdom | Series C, Series A | Cyber Security, Security, Network Security | |
|
Peer Schatz
Angel
|
1 | United States, United Kingdom | Seed | Medical, Genetics, Health Care | |
|
Susan Lowther
Angel
|
1 | United Kingdom | Post-IPO Equity | Biopharma, Education, Biotechnology | |
|
Sam Fazeli
Angel
|
1 | United Kingdom | Post-IPO Equity | Biopharma, Education, Biotechnology | |
|
Silla Scheepens
Angel
|
1 | United Kingdom | Seed | Biotechnology, Food Processing, Food and Beverage | |
|
Jim Warwick
Angel
|
1 | United Kingdom | Seed | Life Science, Biotechnology | |
|
David Rowan
Angel
|
1 | United Kingdom, Germany, Croatia | Seed, Pre-Seed | Software, Artificial Intelligence, Information Technology | |
|
Siddhant Jayakumar
Angel
|
1 | United Kingdom | Pre-Seed | Biotechnology, Public Safety, Artificial Intelligence | |
|
Emma Watson
Angel
|
1 | United Kingdom | Series A | Chemical, Biotechnology, Nanotechnology | |
|
Chris Gibson
Angel
|
1 | United States, France, Switzerland | Series A, Seed | Biotechnology, Health Care, Life Science | $4.9M–$55M |
|
Richard Fearn
Angel
|
1 | United Kingdom, United States | Seed, Pre-Seed, Series A | Software, Advertising, Internet | $550k–$13M |
| Access all 212 angel investors in United Kingdom Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 61
- Round size: Seed $537k–$25M; Series A $4.1M–$50M; Series B $1.6M–$56M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Biotechnology, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 15
- Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$19M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 54
- Round size: Seed $150k–$6.7M; Pre-Seed $110k–$5M; Series A $13M–$60M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund
Show more...Investment focus
- Industry: Biotechnology, Machine Learning
- Stage:Seed, Convertible Note
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 191
- Round size: Seed $1.1M–$8M; Pre-Seed $500k–$5.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Skrap — Skrap is an on-demand mobile marketplace for skip hire and other waste collection services.
- Hyphen SCS — Find and rent verified warehouses across 992+ cities in India. Compare 65,000+ listings on Hyphen SCS.
- Structured AI — AI-powered QA/QC for construction documents. Structured catches errors before they reach the field.
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 58
- Round size: Seed $1.4M–$5M; Angel $70k–$1.3M; Pre-Seed $1M–$2.8M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Clara —
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
- Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 17
- Round size: Seed $100k–$45M; Pre-Seed $874k–$2.2M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Freatic — Building the monetization layer for your alpha
- Niulinx — Niulinx specializes in providing autonomous driving technology solutions based on artificial intelligence, connectivity, and data analytics.
- Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham.
Show more...Investment focus
- Industry: Software, Wellness, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Japan
Investor stats
- Total investments: 17
- Round size: Seed $3M–$6.6M; Pre-Seed $539k–$1M; Series A $6.9M–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Stelia — Stelia builds distributed AI platforms that scale globally. Research-driven intelligent systems for healthcare, education, and enterprise operations worldwide
- Epiminds — Epiminds develops multi-agent AI systems to run marketing end-to-end.
- Scooch — All-in-one subscription to eliminate hassle from your pet healthcare. From online assessment, health tracking and AI assistant to 24/7 vet support and vet-formulated treatments.
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Japan
Investor stats
- Total investments: 101
- Round size: Seed $2.5M–$35M; Pre-Seed $450k–$2.3M; Series A $10M–$60M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
- Moonlake AI — Vibe code games and worlds into existence.
- Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 56
- Round size: Seed $1.5M–$7.9M; Pre-Seed $668k–$7.5M; Series A $11M–$28M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Cordless — Bridging the gap between voice and text
- Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Pano Kroko is a legendary entrepreneur, Angel, VC and PE investor in innovation towards solving big problems. His investment emphasis is on Life Sciences, Biotech, Therapeutics, Medicine, Internet, Mobile, Communications, Clean Technology, Renewable Energy, and Environmental Finance. We have a quarterly Business Plan competition for placementin our early stage start up accelerator in Seattle Washington. We also run a program in Washington DC, and we have an Innovation Master Class Startup Weekend that runs Ten times a year in Seattle, Beijing, Silicon Valley, and in major Universities around the world.The Accelerator in Seattle & Silicon Valley is called American Angels, and the Accelerator in Washington DC is named H2O and both accept business plans and great ideas with Founders, and Executive teams right now. We would like to see StartUps in all of our areas of focus as well as anything else that is great and promising to solve Big Problems. Parallel to this we also run the CEP - Clean Energy Program incubator in Oxford UK, and the Biotech accelerator for genetics, stem cell applications, genomics, medicine, pharma and telomeres research in Cambridge UK.For our more traditional VC and PE work in the US, the American Venture Company in the US and the Investment Bank Green Capital Inc in the UK and Europe. These are our conduits of support for companies and also the Green Bonds Investments Plc. All of our organizations act as levers of positive change for impact investing, and as corporate environmental investment responsibility -- within the Finance community.In Seattle and in Silicon Valley we run the Accelerator and Early Stage Investment firm AMERICAN ANGELS where we have monthly pitches and demos for new StartUps and we also run a CEO roundtable to help promising Entrepreneurial leaders to succeed.If you or your company is interested in cooperation, presenting, funding, deal syndication or simply for submission of Executive Summaries and Business Plans for early stage angel funding and/or inclusion in the H2O Incubator/Accelerator or the Clean Energy program and the Biotech incubator, please contact us herewith: Mr Ruddy Wallace: envpar [at] gmail.com
Show more...Investment focus
- Industry: Health Care, Therapeutics, Biotechnology
- Stage:Angel, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 3
- Round size: Angel $150k–$458k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amrit Advanced Biotech — Company working in Genetics, Telomeres health applications, cancer mitigation and lengthening of....
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Big Data
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Round size: Seed $458k–$3.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
- Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
- Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Pratima is a Venture Partner at Nauta Capital and is based in London. At Nauta, Pratima focuses on enterprise software and deep tech domains.Pratima has 18+ years of professional experience. She is a software developer by background and spent several years in Silicon Valley working on developing intelligent network services in the networkmanagement domain. Pratima joins Nauta from US-based cybersecurity-focused investment firm Paladin Capital. Previously, Pratima led investments and acquisitions at Cisco Corporate Development in Europe with a specific focus on ML/AI, Enterprise Collaboration and Silicon. During her investment career, Pratima led an investment or held board seats in Aimotive, Adbrain, Evrythng, Secure Code Warrior, decentriq, Dashbird, and several fund investments. She also managed investments in several companies including Behaviosec, Italtel, ip.access, and Corvil.Pratima received her MBA from INSEAD in France and an MS in computer science from the Virginia Polytechnic Institute and State University in the US. Pratima is a co-author of a US patent in the area of network device clusters and high availability.
Show more...Investment focus
- Industry: SaaS, Software, Analytics
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Germany
Investor stats
- Total investments: 11
- Round size: Seed $1.2M–$8.3M; Pre-Seed $982k–$1.2M; Series A $7M–$12M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
- Treblle — Treblle is a lightweight SDK that helps Engineering and DevOps teams build, ship & maintain REST based APIs faster
- Mindflow — Mindflow is a No-Code & Agentic Automation & Orchestration Platform that enables all Enterprise Cyber IT Professionals to Automate Mundane tasks and to deploy AI Agents at scale.
Gilad Engel
Show more...Investment focus
- Industry: Hardware, Analytics, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: France, Israel, United Kingdom
Investor stats
- Total investments: 4
- Round size: Seed $1.2M–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Joe — Joe is an financial service that reimburses and allows ALL expenses to be paid in several installments.
- Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
- Fourier Optics — Fourier optics creates meta-surface based optical systems for Augmented Reality glasses
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more...Investment focus
- Industry: FinTech, E-Commerce, Financial Services
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $500k–$9M; Angel $233k–$1M; Pre-Seed $1.2M–$2M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
- Permisso — Bankflip is a mobile application that collects and processes income, tax, employment, and relevant data in real-time.
- Momento — Momento is an insurtech company with the objective of revolutionizing the insurance industry in Latin America, starting with car insurance. We want to make insurance easy and accessible for the underserved population in LATAM.
Patrick Pichette is based out of London, England, and is the Partner of Inovia Capital and also Board Member of Cohere. Patrick Pichette previously worked at Twitter as a Board of Directors. Patrick Pichette attended the University of Oxford.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 25
- Round size: Seed $943k–$10M; Series A $10M–$95M; Series B $15M–$95M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Mobai — Provider of attack detection, image manipulation detection and authentication. Strong and successful research team on biometrics.
- Kaedim — AI-powered 3D asset creation service delivering fast, production-ready 3D assets. Scale 3D pipelines without hiring, accelerate 3D game art production, and reduce 3D asset costs by up to 90%.
- Clove — Building the financial institution of the future.
Jon Oringer is the founder and chairman of Shutterstock.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 115
- Round size: Seed $375k–$5.5M; Pre-Seed $175k–$2.5M; Series A $4M–$56M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
- Unsloth AI — Unsloth is an open-source, no-code web UI for training, running and exporting open models in one unified local interface.
- OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.
Mati Staniszewski is the Co-Founder of ElevenLabs.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Poland
Investor stats
- Total investments: 19
- Round size: Seed $5M–$17M; Pre-Seed $2M–$20M; Series A $16M–$75M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CodeWords —
- Viktor —
- Pocket — Pocket is a technology company that develops an AI-enabled note-taking system combining a dedicated recording device with companion software. Its platform records in-person conversations and phone calls, transcribes audio, and organizes the content into searchable transcripts, summaries, action items, and mind maps. The system supports offlinerecording, cloud synchronization, and access across mobile, desktop, and web applications, with support for more than 120 languages. Pocket also provides AI-powered features for organizing, searching, and exporting recorded information while offering integrations with task management workflows. Its products are designed for individuals and teams who need to capture, organize, and retrieve information from conversations and spoken ideas.
Chris Mairs - Venture Partner @ Entrepreneurs First
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Pre-Seed, Angel
- Geography: United Kingdom, United States
Investor stats
- Total investments: 25
- Round size: Seed $655k–$3.7M; Angel $334k–$707k; Pre-Seed $900k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
- Incard — Welcome to the world's first payment solution designed exclusively for e-commerce, entrepreneurs, dropshippers and influencers. Join our waitlist now.
- Briefcase — Automate your accounting workflows with AI
Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 17
- Round size: Seed $2.8M–$12M; Pre-Seed $1.8M–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- DatologyAI — DatologyAI optimize training efficiency, maximize performance and reduce compute costs with expert curation.
- Extropic AI — The next era of computing isn't dead. It's alive. More coming soon.
- Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 118
- Round size: Seed $150k–$18M; Series A $5.8M–$36M; Series B $19M–$120M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
- Odyssey — Odyssey operates as an AI start-up, provides hollywood-grade visual AI.
Nadav Ben-Chanoch
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 178
- Round size: Seed $329k–$5.5M; Pre-Seed $100k–$2.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- micro1 — We help companies hire and manage the best software engineers easily.
- TRIVER — Triver develops online and digital tools to assist and support various financial services. It is based in London, England.
- Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Series A, Seed, Series C
- Geography: United Kingdom, United States, The Netherlands
Investor stats
- Total investments: 35
- Round size: Seed $1.4M–$8M; Series A $3.2M–$24M; Series C $8M–$24M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- 8fit — Get personalized workouts, custom meal plans, and nutrition guidance, right in the palm of your hand. Prioritize progress over perfection with the 8fit app!
- Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.
Show more...Investment focus
- Industry: SaaS, Software, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 38
- Round size: Seed $459k–$3.1M; Pre-Seed $605k–$1M; Series A $3.2M–$16M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
- Realla — Search the entire commercial property market for offices, serviced office space, retail, industrial for sale and to rent
- IVO — Platform to allow media owners to deepen advertiser engagement, increase profitability and commercialise ad solutions with ease.
Serge Chiaramonte
Show more...Investment focus
- Industry: FinTech, Financial Services, Information Technology
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 59
- Round size: Seed $1.2M–$4.9M; Pre-Seed $637k–$37M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Desia — Desia provides advanced AI applications for productivity, automation, and analytics for financial services.
- Tranched — Introducing real-time on-chain securitisation. Fintech Lenders and Professional Investors can now launch an institutional-grade transaction up to 90% faster than before.
- Juno — Meet Juno, a workplace wellbeing programme that you control.
Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 80
- Round size: Seed $1.1M–$7.2M; Pre-Seed $1.1M–$3.5M; Series A $3.9M–$18M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Oraion — Your single source of truth for enterprise data
- Capsa AI — Providing next-generation investors with a competitive edge.
- Habito — We're the Treating Customers Fairly Champion of 2023 as voted for in the British Bank Awards. We're here to make mortgages easier - no paperwork, no stress and no fees.
Ed Parkinson
Show more...Investment focus
- Industry: Software, Health Care, Life Science
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Round size: Seed $1.8M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
Michelle Tempest
Show more...Investment focus
- Industry: Health Care, Biotechnology, Cannabis
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Daye — Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana).
- Sanome — Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people.
- Medwise.ai — Medwise.ai is the Google for doctors.
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Health Care
- Stage:Series A, Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 29
- Lead/follow: no public data
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.
Show more...Investment focus
- Industry: Software, SaaS, Financial Services
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 18
- Round size: Seed $962k–$2.5M; Series A $6.4M–$13M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Mitra bio — We are transforming skin-care by approaching ageing as a disease to be fought. We are developing a genetic and epigenetic discovery platform to help skincare companies find and develop new compounds that actually fight the root cause of skin ageing.
- PPC Protect — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media
- AeroCloud — Reinvent airport management with cloud-based software that enhances efficiency, unifies operations, and helps airports deliver a seamless, people-first experience.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
Show more...Investment focus
- Industry: Software, Social Media, Internet
- Stage:Seed, Series A, Angel
- Geography: United States, Spain, Mexico
Investor stats
- Total investments: 45
- Round size: Seed $455k–$7M; Angel $1M–$1.7M; Series A $3M–$7.9M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
- Kiwibot — Delivery robots to optimize your business and deliver safely and timely to your customers.
- Grin Scooters — Grin Scooters is a software company that operates network of operational shared electric scooters. Currently, Grin only operates in Mexico City, Guadalajara, Monterrey, Sao Paulo and Bogota but it has plans to expand to other cities throughout Latin America.
Robert Kopple
Show more...Investment focus
- Industry: FinTech, Finance, Life Science
- Stage:Convertible Note
- Geography: United States, United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
- ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Hugh Grant is President and Chief Executive Officer at Monsanto.
Show more...Investment focus
- Industry: Biotechnology, Machine Learning
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 344
- Round size: Seed $605k–$6.1M; Pre-Seed $125k–$3.6M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Humera — Humera develops AI-based solutions for CAPTCHA and bot detection, focusing on minimizing user disruption during online verification processes. Its technology uses real-time machine learning to identify bots and prevent fraud without relying on traditional visible CAPTCHA challenges. The system aims to help platforms detect automated activity whilemaintaining user privacy and reducing friction for legitimate users.
- Allonic —
- Heywa Labs — Heywa Labs develops Generative UX (GenUX), an AI-driven interface layer that creates dynamic, adaptive user experiences beyond static text or links. Their flagship app, Heywa, delivers visual, tappable "stories" of cards for tasks like cooking, travel, fitness, and DIY, reconfiguring in real-time based on user interactions.
Amar Shah is based out of London and is the Founder & Partner of Dhyan VC. Amar previously worked at Firstminute Capital as an Entrepreneur In Residence. Amar Shah attended the University of Cambridge.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Pre-Seed, Seed, Angel
- Geography: United Kingdom, Poland, Germany
Investor stats
- Total investments: 10
- Round size: Seed $4.8M–$15M; Pre-Seed $642k–$2.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- sensmore — Equip your machinery with autonomy built for the harshest conditions. Enhance safety, reduce costs, and increase efficiency with our advanced radar technology.
- ReSpo.Vision — Enhance your sports analytics and visualise the game using AI & Computer Vision-powered Sports Tracking and Event Data.
- TextCortex — Create the highest quality content 7x faster, using TextCortex AI - the best copywriting tool for all your content. Get started for free, no credit card required.
Marty Chavez is executive vice president and chief financial officer of The Goldman Sachs Group, Inc. He is a member of the Management Committee, Firmwide Capital Committee, Firmwide Risk Committee and Steering Committee on Regulatory Reform. Marty is also a member of the Firmwide Hispanic/Latino Network and the Lesbian, Gay, Bisexual andTransgender Network.Marty first joined Goldman Sachs in 1993 in the J. Aron Currency and Commodities Division, where he was a senior energy strat until 1997. He returned to the firm as a managing director in Investment Banking Division Strats in 2005, becoming global co-head of Securities Division Strats and then global co-chief operating officer of the Equities Franchise. Prior to assuming his current role, Marty was chief information officer, responsible for the Technology Division and jointly responsible with divisional leadership for the firm’s global strategists. He was named partner in 2006.Prior to first joining the firm, Marty was co-founder and chief technology officer of Quorum Software Systems from 1989 to 1993. From 1997 to 2000, he was global head of energy derivatives at Credit Suisse Financial Products. In 2000, Marty co-founded Kiodex, Inc. and was chairman and chief executive officer until 2004.Marty serves on the Harvard Board of Overseers and is a Fellow of the New York Academy of Medicine.Marty earned a PhD in Medical Information Sciences from Stanford University in 1990, an SM in Computer Science from Harvard University in 1985, and an AB, magna cum laude, in Biochemical Sciences from Harvard College in 1985.
Show more...Investment focus
- Industry: Health Care, Machine Learning, Biotechnology
- Stage:Series A, Seed, Private Equity
- Geography: United States, United Kingdom
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Hebbia — Hebbia's neural search lets you execute research 10X faster and 10X more accurately. Transform your productivity today.
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- VMind AI — VMind is a frontier technology company building artificial general intelligence (AGI).
Ahmed Medhat - Research Scientist, Core Data Science @ Meta
Show more...Investment focus
- Industry: Information Technology, Apps, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: United States, United Kingdom
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- Ntropy Network — Unlock the power of transactions. Our technology enables flexible and autonomous banking data cleansing, labeling and enhancement.
- OASIS AI — All you do is talk. AI does the rest.
- Grin Gaming — GrinData micro markets software leverages best-in-class high-frequency trading and machine learning to deliver reliable odds pricing on the most markets.
Huw Bishop is an individual investor.
Show more...Investment focus
- Industry: EdTech, Training, E-Learning
- Stage:Angel
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- clear_pixel VR — Virtual reality training platform that helps increase your laboratory skills and reduces laboratory breakages and costs
Sam Harris
Show more...Investment focus
- Industry: Wellness, Elder Care, Health Care
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Decorte Future Industries — DFI augments humanity through intelligent clothing. We care for the most vulnerable and empower those pushing the edges of human ability.
David G. DeWalt is the Founder and Managing Director of Dave DeWalt. He joined AllegisCyber Capital as a Managing Director in 2017. Dave is a renowned cybersecurity executive, having taken cyber industry leader FireEye public (Chairman & CEO) and served as the CEO of both McAfee and Documentum.He is a member or leader of six boards ofdirectors, including ForgeRock, ForeScout, Phantom Cyber, and OPTIV, and serves as the Vice Chairman of Delta Airlines. Dave consults regularly with government, industry players, and the corporate Board of Directors on matters related to cybersecurity policy, technology, and strategy.He holds a B.S. in computer science from the University of Delaware.
Show more...Investment focus
- Industry: Cyber Security, Security, Network Security
- Stage:Series C, Series A
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Callsign — Marking a new era in passive authentication, fraud prevention and intelligence. We make digital identity simple and more secure.
- Instant Channel — Instant Channel, Inc. is an advertising and marketing company that provides email marketing and communications services in the State of California.
- Blackbird.AI — Blackbird.AI provides organizations with Deception Detection technology to protect against narrative manipulation and disinformation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Seed
- Geography: United States, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Valar Labs — AI to Make Oncologists Smarter
- Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.
Susan joined IXICO as Chief Financial Officer in October 2014. She is an experienced Executive Director with previous Board positions including Group Chief Financial Officer of Novacyt SA and Chief Financial Officer of Lab21 prior to its acquisition by Novacyt. Susan was Chief Financial Officer of BioWisdom until its acquisition by Instem plc andFinance Director of RiboTargets Limited until its acquisition by Vernalis plc.
Show more...Investment focus
- Industry: Biopharma, Education, Biotechnology
- Stage:Post-IPO Equity
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Arecor — Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.In addition toits internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Sam Fazeli is the Non Executive Director at Arecor Limited.
Show more...Investment focus
- Industry: Biopharma, Education, Biotechnology
- Stage:Post-IPO Equity
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Arecor — Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.In addition toits internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Silla Scheepens of Future Food Fund.
Show more...Investment focus
- Industry: Biotechnology, Food Processing, Food and Beverage
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Extracellular — Extracellular is a scale-up and development partner, channelling biology, digitalisation and biomanufacturing expertise to accelerate the potential of cultivated meat.
Jim started work at Analysys Limited, a Cambridge-based telecommunications consultancy, heading up its IT, software and web development initiatives. Jim then joined Abcam as a Technical Director, and took over the operational management of the UK office as Managing Director in June 2004, working on both cost saving and efficiency improvementprojects. In 2009, Jim became Chief Operating Officer, with the responsibility for overseeing the operational strategy of the Group. Jim is a Director of Chesterton Community College, Chesterton Sports Centre Limited and Cambridge Nutraceuticals Limited. He has also taken up a non-executive position at Quartix Holdings Plc. Jim had over 15 years’ experience in developing and implementing IT systems and strategy before moving into a broader operational management role within Abcam.Here his skills have been particularly focused on developing a scalable operating model for Abcam which, supported by IT systems, has underpinned Abcam’s rapid growth over the past decade.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Qkine — Growth Factors made for stem cells Animal-free We control every step of protein manufacture ensuring all our products are completely animal-free Total transparency Stringent purity and bioactivity testing data for all proteins - know what you are giving your cells Protein innovation Our R&D team
David Rowan is editor of the UK edition of WIRED magazine, which won 2009 Launch of the David Rowan is Editor of the WIRED UK, the technology and trends magazine covering online brands, gadgets and the culture that surrounds them. David has reported on technology for The Times and Channel 4 News, the latter requiring him to illustrate the newiPod Video from the set of a porn shoot. He's also written for The Sunday Times and Telegraph Magazines, and edited the Guardian's on-line content. David has curated an exhibition of British creative talent at the Government's Cabinet Forum conference. He has also addressed the TEDs, and frequently contributes on Newsnight and the Today programme. He also writes a monthly column for GQ. David is in touch with many of the world's leading trend-setters and spotters. In presentations he looks at how the net is disrupting almost every sector, how apps change consumer behaviour and why 'social commerce' is killing traditional marketing. He reveals the 10 trends that will change your market in the next decade - and what you should be doing now to protect yourself.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Germany, Croatia
Investor stats
- Total investments: 24
- Lead/follow: no public data
Portfolio highlights
- EWOR — EWOR is a platform dedicated to transforming aspiring entrepreneurs into successful startup founders through world-class education, mentorship, and investment opportunities.
- Climate X — Climate X combines climate science and econometrics to deliver precise climate risk data without any black boxes.
- Rhizocore Technologies — We develop high-performance strains of locally-sourced mycorrhizal fungi to improve tree growth, tree health and tree resiliency. We offer a sustainable solution to increase forest yields whilst improving the ability of trees to sequester carbon.
Siddhant Jayakumar
Show more...Investment focus
- Industry: Biotechnology, Public Safety, Artificial Intelligence
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- sable bio — We reinvent drug safety through cutting-edge AI-driven data and predictive analytics. Empowering researchers with state-of-the-art tools that integrate and expand on multimodal evidence, we propel the development of safe and effective medicines.
Emma Watson
Show more...Investment focus
- Industry: Chemical, Biotechnology, Nanotechnology
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FabricNano — Powered by DNA nanotechnology, FabricNano has the expertise to fine-tune enzyme performance and produce biochemicals.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 10
- Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Inato — Inato matches the right sites to the right clinical research study, globally.
- Known Medicine — Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Richard started in his career in advertising but has since shifted his attention to start-ups. As an investor/advisor to over 50 early stage companies, including Sofar Sounds, Blaze, Dojo & What3Words, Richard has learnt a lot about what it takes to launch & grow a start-up. He also the co-founder of the ‘Friday Club London,’ a‘non-profit’ events company aimed at providing start-ups free access to senior marketing expertise. Since launching, over 250 start-ups have benefitted from the programme. And in exchange for their advice, industry mentors have had access to the UK’s brightest founders. In 2013 & 2014 Richard was named in BIMA’s ‘Hot 100’ list and in 2016 and 2017 short-listed for the Europas ‘Investor of the Year’ award.
Show more...Investment focus
- Industry: Software, Advertising, Internet
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 33
- Round size: Seed $550k–$2M; Pre-Seed $585k–$1.9M; Series A $1.7M–$13M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Darabase — Darabase is a unique platform enabling the creation, management and monetisation of location-based digital content in the real world and virtual metaverses.
- Roleshare — Roleshare matches freelancers, part-time and fractional workers to job share; helping companies retain and attract coveted skills and talent. Join us!
- Unlock — Unlock is a video-based platform packed with unique experiences your team will love.
Biotechnology Angel investor funding in United Kingdom at a glance
Stats across 176 deals from 212 investors.
Access all 212 angel investors in United Kingdom Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 212 angel investors investing in United Kingdom Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!